Dr. Ramesh C. Narayanagowda, MD

Dr. Narayanagowda practices at SurgiCenter of Murfreesboro Medical Clinic in Murfreesboro, Tennessee.

Dr. Narayanagowda's NPI, 1578551917, was assigned on October 10, 2005. Dr. Narayanagowda holds Tennessee license MD35831.

Dr. Narayanagowda's primary practice is SurgiCenter of Murfreesboro Medical Clinic, at 1272 Garrison Drive, Murfreesboro, TN 37129. The practice phone is (615) 893-4480.

Dr. Narayanagowda's primary practice is SurgiCenter of Murfreesboro Medical Clinic in Murfreesboro, Tennessee. Dr. Narayanagowda is also affiliated with Ascension Saint Thomas Rutherford. The medical group on file is Murfreesboro Medical Clinic & SurgiCenter. Dmand AI also links Dr. Narayanagowda to 1 more group practice or clinic, named with a free account. Dr. Narayanagowda's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Narayanagowda practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Narayanagowda's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Narayanagowda is licensed in Tennessee.

CMS data shows 1,379 Medicare services from Dr. Narayanagowda across 17 procedure codes in 2024, for 386 Medicare patients. Medicare paid $149,901 for them.

CMS counts 386 Medicare patients who saw Dr. Narayanagowda in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Narayanagowda's median patient age at 71, with 54% women.

In 2024, Dr. Narayanagowda wrote 403 Medicare Part D claims for 156 patients. 93% of them were for generic drugs. CMS names the drug for 356 of them, across 8 drugs with 11 or more claims each, at $17,242 in total drug cost. In 2023, CMS named 239 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Narayanagowda for performance year 2024, reported through an alternative payment model (APM). Dr. Narayanagowda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of varicose vein removal by Dr. Narayanagowda, more than 88% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 64 general payments to Dr. Narayanagowda from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Boston Scientific Corporation paid the most, $6,304.